版本:
中国

BRIEF-Krensavage Asset Management urges Juniper Pharmaceuticals to consider sale

April 12 Juniper Pharmaceuticals Inc

* Krensavage Asset Management urges Juniper Pharmaceuticals to consider sale of company

* Krensavage Asset Management LLC, a 2.2% shareholder of Juniper Pharmaceuticals, publishes open letter Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐